Barclays Predicts Oscar Health Will Benefit Most from ACA Boom
Barclays raised Oscar Health rating, sees higher price target as ACA growth and pricing gains boost future profits.
Barclays raised Oscar Health rating, sees higher price target as ACA growth and pricing gains boost future profits.
Wells Fargo upgraded Oscar Health, citing a better 2026 outlook, improving costs, and stronger-than-expected enrollment.
Oscar Health posted record profit, strong growth, and lower costs, showing a major turnaround and fast expansion.
Oscar Health CEO bought $11.9M in shares after stock payout, showing strong confidence. Shares jumped.
Raymond James upgrades Oscar Health stock to Outperform with $18 target, calling valuations attractive as margins improve in ACA market and forward outlook strengthens.
Oscar Health reports wider quarterly losses due to higher medical costs, while revenue grows and the company targets profitability in 2026.